2022 ICD-10-CM Code C67

Malignant neoplasm of bladder

Version 2021

Not Valid for Submission

Short Description:Malignant neoplasm of bladder
Long Description:Malignant neoplasm of bladder

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of urinary tract (C64-C68)
      • Malignant neoplasm of bladder (C67)

C67 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of bladder. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding for Malignant neoplasm of bladder

Non-specific codes like C67 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for malignant neoplasm of bladder:

  • BILLABLE CODE - Use C67.0 for Malignant neoplasm of trigone of bladder
  • BILLABLE CODE - Use C67.1 for Malignant neoplasm of dome of bladder
  • BILLABLE CODE - Use C67.2 for Malignant neoplasm of lateral wall of bladder
  • BILLABLE CODE - Use C67.3 for Malignant neoplasm of anterior wall of bladder
  • BILLABLE CODE - Use C67.4 for Malignant neoplasm of posterior wall of bladder
  • BILLABLE CODE - Use C67.5 for Malignant neoplasm of bladder neck
  • BILLABLE CODE - Use C67.6 for Malignant neoplasm of ureteric orifice
  • BILLABLE CODE - Use C67.7 for Malignant neoplasm of urachus
  • BILLABLE CODE - Use C67.8 for Malignant neoplasm of overlapping sites of bladder
  • BILLABLE CODE - Use C67.9 for Malignant neoplasm of bladder, unspecified

Information for Patients

Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute

[Learn More in MedlinePlus]

Bladder cancer

Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply uncontrollably to form a tumor. The bladder is a muscular organ in the lower abdomen that stores urine until it can be removed (excreted) from the body.

Bladder cancer may cause blood in the urine, pain during urination, frequent urination, the feeling of needing to urinate without being able to, or lower back pain. Many of these signs and symptoms are nonspecific, which means they may occur in multiple disorders. People who have one or more of these nonspecific health problems often do not have bladder cancer, but have another condition such as an infection.

Bladder cancer develops when tumors form in the tissue that lines the bladder. There are several types of bladder cancer, categorized by the type of cell in the tissue that becomes cancerous. The most common type is transitional cell carcinoma (also known as urothelial carcinoma); others include squamous cell carcinoma and adenocarcinoma. If the tumor spreads  (metastasizes) beyond the lining of the bladder into nearby tissues or organs, it is known as invasive bladder cancer. 

[Learn More in MedlinePlus]

Bladder Cancer Summary Learn about bladder cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)